These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 9241913)

  • 1. Circulating soluble L-selectin levels in Kawasaki disease with coronary artery lesions.
    Hirao J; Yamashita T
    Acta Paediatr Jpn; 1997 Apr; 39(2):290-2. PubMed ID: 9141275
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma fibronectin concentrations in mucocutaneous lymph node syndrome.
    Shimizu S; Kuratsuji T; Ojima T; Takahashi E
    Arch Dis Child; 1986 Jan; 61(1):72-4. PubMed ID: 3954421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of CD23 on peripheral blood macrophages/monocytes during acute Kawasaki disease with coronary artery lesions.
    Furukawa S; Matsubara T; Okumura K; Yabuta K
    Int Arch Allergy Immunol; 1993; 102(4):335-9. PubMed ID: 7694701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
    Ohno T; Igarashi H; Inoue K; Akazawa K; Joho K; Hara T
    Eur J Pediatr; 2000 Jun; 159(6):424-9. PubMed ID: 10867847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease by fluorescence activated cell sorter using two-colour immunofluorescence staining].
    Jujho K
    Arerugi; 1985 Dec; 34(12):1072-80. PubMed ID: 2420314
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating soluble CD23 levels in Kawasaki disease with coronary artery lesions.
    Hirao J; Yamashita T
    Acta Paediatr Jpn; 1997 Jun; 39(3):397-9. PubMed ID: 9241913
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sequelae of Kawasaki disease].
    Takase B; Ohtomi S
    Ryoikibetsu Shokogun Shirizu; 1996; (15):406-10. PubMed ID: 9048054
    [No Abstract]   [Full Text] [Related]  

  • 8. The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease.
    Teraura H; Kotani K; Minami T; Takeshima T; Shimooki O; Kajii E
    Ann Clin Biochem; 2017 Mar; 54(2):209-213. PubMed ID: 28081636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for Kawasaki disease.
    Kitamura S; Kameda Y; Kawashima Y
    Adv Card Surg; 1997; 9():177-94. PubMed ID: 9463714
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous transluminal coronary angioplasty for Kawasaki disease: a case report and literature review.
    Ino T; Nishimoto K; Akimoto K; Park I; Shimazaki S; Yabuta K; Yamaguchi H
    Pediatr Cardiol; 1991 Jan; 12(1):33-5. PubMed ID: 1997981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki syndrome.
    Rowley AH; Gonzalez-Crussi F; Shulman ST
    Rev Infect Dis; 1988; 10(1):1-15. PubMed ID: 3281216
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.